PDCD10/CCM3, a potential target for pancreatic ductal adenocarcinoma?
Clinical Science · 2025
DOI: 10.1042/cs20241916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2025. Verfasst von Hendrik Ungefroren. Beteiligte Einrichtung: First Department of Medicine, University Hospital Schleswig-Holstein (UKSH), and University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Apoptosis Regulatory Proteins, Pancreatic Neoplasms, Proto-Oncogene Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Malignant progression of pancreatic ductal adenocarcinoma (PDAC) is driven by transforming growth factor (TGF)-β1 through extensive cross-talk with other signalling pathways. Prompted by the observation that the ubiquitous protein programmed cell death 10 (PDCD10) is more abundantly expressed in PDAC tumour tissue compared with normal pancreas and highly correlated with reduced patient survival, authors examined its function as a modulator of TGF-β signalling in PDAC. Cytotoxicity assays with PDAC-derived tumour cell lines, PaTu8902 (DPC4+/+) and PaTu8988t (DPC4-/-) engineered to homozygously lack PDCD10 showed that PDCD10 renders cells more chemoresistant to anticancer drugs. Moreover, PDCD10 promoted TGF-β1-dependent proliferation by inactivating the retinoblastoma 1 protein (pRb) via a SMAD4-dependent pathway, and TGF-β1-driven EMT by increasing ERK1/2 activation via a non-SMAD4 pathway. Phosphorylation of pRB and ERK by PDCD10 is facilitated by binding of PDCD10 to MST4. Targeting PDCD10 in PDAC patients may represent a promising new strategy to improve TGF-β targeted therapies
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Department of Medicine, University Hospital Schleswig-Holstein (UKSH), and University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.
ORCID-Profile: Hendrik Ungefroren
Zitieren
APA
Ungefroren, H. (2025). PDCD10/CCM3, a potential target for pancreatic ductal adenocarcinoma?. Clinical Science. https://doi.org/10.1042/cs20241916
Vancouver
Ungefroren H. PDCD10/CCM3, a potential target for pancreatic ductal adenocarcinoma?. Clinical Science. 2025. doi:10.1042/cs20241916
BibTeX
@article{Ungefroren2025,
author = {Ungefroren, Hendrik},
title = {PDCD10/CCM3, a potential target for pancreatic ductal adenocarcinoma?},
journal = {Clinical Science},
year = {2025},
doi = {10.1042/cs20241916}
}
EUVIMED